Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Covance
Biotech
GSK vaccine exec hits the exit—Chutes & Ladders
GSK loses another vaccine exec; Covance's Franklin steps up to run cell and gene therapy; Kite taps Marincola for cell therapy research.
Fraiser Kansteiner
Jan 22, 2021 9:30am
Covance boosts Franklin to lead its cell and gene therapy unit
Jan 20, 2021 7:05am
The rise and rise of the virtual trial model
Dec 22, 2020 7:00am
Covance starting to rebound, but trial business struggles
Oct 27, 2020 9:00am
Covance to 'transform' into a decentralized CRO
Oct 20, 2020 8:10am
Covance teams up with Tempus with time on its mind
Sep 16, 2020 9:55am
